Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 208

1.

Impact of depression on HIV outcomes in the HAART era.

Hartzell JD, Janke IE, Weintrob AC.

J Antimicrob Chemother. 2008 Aug;62(2):246-55. doi: 10.1093/jac/dkn193. Epub 2008 May 2. Review.

PMID:
18456650
[PubMed - indexed for MEDLINE]
Free Article
2.

Psychiatric illness and virologic response in patients initiating highly active antiretroviral therapy.

Pence BW, Miller WC, Gaynes BN, Eron JJ Jr.

J Acquir Immune Defic Syndr. 2007 Feb 1;44(2):159-66.

PMID:
17146374
[PubMed - indexed for MEDLINE]
3.

Effects of depression and selective serotonin reuptake inhibitor use on adherence to highly active antiretroviral therapy and on clinical outcomes in HIV-infected patients.

Horberg MA, Silverberg MJ, Hurley LB, Towner WJ, Klein DB, Bersoff-Matcha S, Weinberg WG, Antoniskis D, Mogyoros M, Dodge WT, Dobrinich R, Quesenberry CP, Kovach DA.

J Acquir Immune Defic Syndr. 2008 Mar 1;47(3):384-90.

PMID:
18091609
[PubMed - indexed for MEDLINE]
4.

Characteristics and outcomes of HIV-infected patients in the ICU: impact of the highly active antiretroviral treatment era.

Vincent B, Timsit JF, Auburtin M, Schortgen F, Bouadma L, Wolff M, Regnier B.

Intensive Care Med. 2004 May;30(5):859-66. Epub 2004 Feb 6.

PMID:
14767592
[PubMed - indexed for MEDLINE]
5.

The influence of HCV coinfection on clinical, immunological and virological responses to HAART in HIV-patients.

Carmo RA, Guimarães MD, Moura AS, Neiva AM, Versiani JB, Lima LV, Freitas LP, Rocha MO.

Braz J Infect Dis. 2008 Jun;12(3):173-9.

PMID:
18833399
[PubMed - indexed for MEDLINE]
Free Article
6.

Sex issues in HIV-1-infected persons during highly active antiretroviral therapy: a systematic review.

Nicastri E, Leone S, Angeletti C, Palmisano L, Sarmati L, Chiesi A, Geraci A, Vella S, Narciso P, Corpolongo A, Andreoni M.

J Antimicrob Chemother. 2007 Oct;60(4):724-32. Epub 2007 Aug 21. Review.

PMID:
17715125
[PubMed - indexed for MEDLINE]
Free Article
7.

Bacterial community acquired pneumonia in HIV-infected inpatients in the highly active antiretroviral therapy era.

Madeddu G, Porqueddu EM, Cambosu F, Saba F, Fois AG, Pirina P, Mura MS.

Infection. 2008 Jun;36(3):231-6. doi: 10.1007/s15010-007-7162-0. Epub 2008 May 10.

PMID:
18463787
[PubMed - indexed for MEDLINE]
8.

Effectiveness of highly-active antiretroviral therapy by race/ethnicity.

Silverberg MJ, Wegner SA, Milazzo MJ, McKaig RG, Williams CF, Agan BK, Armstrong AW, Gange SJ, Hawkes C, O'Connell RJ, Ahuja SK, Dolan MJ; Tri-Service AIDS Clinical Consortium Natural History Study Group.

AIDS. 2006 Jul 13;20(11):1531-8.

PMID:
16847408
[PubMed - indexed for MEDLINE]
9.

Progressive multifocal leukoencephalopathy in HIV-infected patients in the era of HAART: radiological features at diagnosis and follow-up and correlation with clinical variables.

Giancola ML, Rizzi EB, Lorenzini P, Rovighi L, Baldini F, Schininà V, Larussa D, Bibbolino C, Antinori A.

AIDS Res Hum Retroviruses. 2008 Feb;24(2):155-62. doi: 10.1089/aid.2006.0252.

PMID:
18240958
[PubMed - indexed for MEDLINE]
10.

The effect of mental illness, substance use, and treatment for depression on the initiation of highly active antiretroviral therapy among HIV-infected individuals.

Tegger MK, Crane HM, Tapia KA, Uldall KK, Holte SE, Kitahata MM.

AIDS Patient Care STDS. 2008 Mar;22(3):233-43. doi: 10.1089/apc.2007.0092.

PMID:
18290749
[PubMed - indexed for MEDLINE]
11.

Patients presenting with AIDS in the HAART era: a collaborative cohort analysis.

Mussini C, Manzardo C, Johnson M, Monforte Ad, Uberti-Foppa C, Antinori A, Gill MJ, Sighinolfi L, Borghi V, Lazzarin A, Miró JM, Sabin C; Late Presenter Investigators.

AIDS. 2008 Nov 30;22(18):2461-9. doi: 10.1097/QAD.0b013e328314b5f1.

PMID:
19005269
[PubMed - indexed for MEDLINE]
12.

Substance abuse and psychiatric disorders in HIV-positive patients: epidemiology and impact on antiretroviral therapy.

Chander G, Himelhoch S, Moore RD.

Drugs. 2006;66(6):769-89. Review.

PMID:
16706551
[PubMed - indexed for MEDLINE]
13.

Impact of ethnicity and HIV type 1 subtype on response to first-line antiretroviral therapy.

de Arellano ER, Benito JM, Soriano V, López M, Holguín A.

AIDS Res Hum Retroviruses. 2007 Jul;23(7):891-4.

PMID:
17678472
[PubMed - indexed for MEDLINE]
14.

Influence of repeated cycles of structured therapy interruption on the rate of recovery of CD4+ T cells after highly active antiretroviral therapy resumption.

León A, Martinez E, Milinkovic A, Mora B, Mallolas J, Blanco JL, Larrousse M, Laguno M, Gallart T, Plana M, Gatell JM, Garcia F.

J Antimicrob Chemother. 2009 Jan;63(1):184-8. doi: 10.1093/jac/dkn461. Epub 2008 Nov 11.

PMID:
19001447
[PubMed - indexed for MEDLINE]
Free Article
15.

Effectiveness of highly active antiretroviral therapy administered by general practitioners in rural South Africa.

Barth RE, van der Meer JT, Hoepelman AI, Schrooders PA, van de Vijver DA, Geelen SP, Tempelman HA.

Eur J Clin Microbiol Infect Dis. 2008 Oct;27(10):977-84. doi: 10.1007/s10096-008-0534-2. Epub 2008 Jul 16.

PMID:
18629557
[PubMed - indexed for MEDLINE]
16.

Predictors for lower quality of life in the HAART era among HIV-infected men.

Liu C, Johnson L, Ostrow D, Silvestre A, Visscher B, Jacobson LP.

J Acquir Immune Defic Syndr. 2006 Aug 1;42(4):470-7.

PMID:
16810114
[PubMed - indexed for MEDLINE]
17.

Predictors of CD4+ cell count response and of adverse outcome among HIV-infected patients receiving highly active antiretroviral therapy in a public hospital in Peru.

López de Castilla D, Verdonck K, Otero L, Iglesias D, Echevarría J, Lut L, Gotuzzo E, Seas C.

Int J Infect Dis. 2008 May;12(3):325-31.

PMID:
18546542
[PubMed - indexed for MEDLINE]
18.

Longer duration of HBV-active antiretroviral therapy is linked to favorable virological outcome in HIV-HBV co-infected patients.

Lee T, Núñez M.

HIV Clin Trials. 2009 May-Jun;10(3):153-9. doi: 10.1310/hct1003-153.

PMID:
19632954
[PubMed - indexed for MEDLINE]
19.

Differential impact of adherence on long-term treatment response among naive HIV-infected individuals.

Lima VD, Harrigan R, Murray M, Moore DM, Wood E, Hogg RS, Montaner JS.

AIDS. 2008 Nov 12;22(17):2371-80. doi: 10.1097/QAD.0b013e328315cdd3.

PMID:
18981777
[PubMed - indexed for MEDLINE]
20.

Retention in opioid substitution treatment: a major predictor of long-term virological success for HIV-infected injection drug users receiving antiretroviral treatment.

Roux P, Carrieri MP, Cohen J, Ravaux I, Poizot-Martin I, Dellamonica P, Spire B.

Clin Infect Dis. 2009 Nov 1;49(9):1433-40. doi: 10.1086/630209.

PMID:
19807275
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk